| Acronym | AIMS-2-TRIALS |
|---|
| Status | Active |
|---|
| Effective start/end date | 1/06/2018 → 31/05/2025 |
|---|
- King's College London (lead)
- F. Hoffmann-La Roche AG
- University of Cambridge
- Catholic University Foundation
- Servicio Madrileño de Salud
- Institut Pasteur
- University of Basel Hospital
- Central Institute of Mental Health Mannheim
- BioSci Consulting
- University of Groningen
- University of Oxford
- INSERM
- University of Edinburgh
- Assistance Publique-Hôpitaux de Paris
- Trinity College Dublin
- Birkbeck, University of London
- Stichting Buro Ecnp
- Noldus Information Technology B.V.
- ARTTIC
- Demcon Advanced Mechatronics BV
- Karolinska Institute
- Goethe University Frankfurt
- UMC University Medical Center Utrecht
- Ghent University
- Newcastle University
- University of Ulm
- CHRU, Centre Hospitalier Regional Universitaire de Tours
- Technical University of Munich
- IRCCS Fondazione Stella Maris
- University of Salamanca
- Glasgow Royal Infirm, University of Glasgow
- French Alternative Energies and Atomic Energy Commission
- University of Göttingen
- Stellenbosch University
- Uppsala University
- University of Coimbra
- Policlinica Gipuzkoa
- FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA
- Janssen Pharmaceutica N.V.
- Novartis Pharma AG
- UCB Biopharma SPRL
- Teva Pharmaceutical Industries Ltd
- Autism Speaks
- SFARI Simons Foundation
- Autistica
- AUTISME-EUROPE AISBL
- University of Bristol
- Starlab SL
- EC European Commission: £44,000,000.00